GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dalian BIO-CHEM Co 603360.SS · CNY

Materials · Shanghai · 🇨🇳 China

Compare

10.00

-1.09%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.72bn

FY2016FY2025

Net income

CN¥209.8m

FY2016FY2025

Free cash flow

CN¥510.0m

FY2016FY2025

Shareholders' equity

CN¥1.39bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥1.72bnCN¥1.31bnCN¥1.07bnCN¥1.26bnCN¥1.01bnCN¥749.5mCN¥871.9mCN¥528.2mCN¥410.4mCN¥389.4m
Gross profitCN¥624.2mCN¥573.9mCN¥544.9mCN¥640.6mCN¥449.7mCN¥400.4mCN¥510.3mCN¥247.7mCN¥197.8mCN¥190.0m
Research and developmentCN¥84.2mCN¥49.7mCN¥39.0mCN¥47.1mCN¥40.0mCN¥28.6mCN¥28.1mCN¥19.1mCN¥15.2mCN¥14.0m
Operating incomeCN¥369.1mCN¥414.5mCN¥385.9mCN¥461.6mCN¥302.7mCN¥260.7mCN¥367.5mCN¥172.1mCN¥126.5mCN¥114.7m
Net incomeCN¥209.8mCN¥345.3mCN¥328.4mCN¥402.6mCN¥250.5mCN¥221.8mCN¥306.8mCN¥145.2mCN¥100.3mCN¥98.3m
Diluted earnings per share0.440.460.470.580.410.320.420.210.160.18

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥3.89bnCN¥3.64bnCN¥1.94bnCN¥1.75bnCN¥1.67bnCN¥1.43bnCN¥1.19bnCN¥897.4mCN¥779.3mCN¥626.4m
Cash and short-term investments—CN¥668.2mCN¥599.5mCN¥418.0mCN¥294.5mCN¥343.4mCN¥242.1mCN¥71.6mCN¥134.2mCN¥114.1m
Total liabilitiesCN¥1.86bnCN¥1.29bnCN¥305.0mCN¥293.1mCN¥621.1mCN¥441.4mCN¥155.8mCN¥99.3mCN¥92.9mCN¥168.3m
DebtCN¥783.3mCN¥532.5mCN¥150.4mCN¥129.1mCN¥338.5mCN¥300.0mCN¥30.0m——CN¥75.0m
Shareholders' equityCN¥1.39bnCN¥1.79bnCN¥1.64bnCN¥1.46bnCN¥1.05bnCN¥988.3mCN¥1.03bnCN¥799.3mCN¥687.5mCN¥458.9m
Shares outstanding475m750m701m689m616m698m736m704m616m552m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥546.7mCN¥163.0mCN¥389.7mCN¥479.9mCN¥142.0mCN¥210.6mCN¥240.1mCN¥135.1mCN¥76.0mCN¥119.8m
Capital spending−CN¥36.7m−CN¥74.9m−CN¥67.4m−CN¥134.3m−CN¥191.6m−CN¥109.2m−CN¥63.0m−CN¥88.5m−CN¥20.2m−CN¥2.9m
Free cash flowCN¥510.0mCN¥88.1mCN¥322.3mCN¥345.6m−CN¥49.6mCN¥101.4mCN¥177.1mCN¥46.7mCN¥55.8mCN¥116.9m
Dividends paid−CN¥331.5m−CN¥223.6m−CN¥206.9m−CN¥6.5m−CN¥150.1m−CN¥112.0m−CN¥72.8m−CN¥34.3m−CN¥134.2m−CN¥6.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥315.9mCN¥263.6mCN¥627.3mCN¥307.2mCN¥300.2mCN¥448.3mCN¥416.1mCN¥312.7m
Gross profitCN¥102.8mCN¥86.2mCN¥248.6mCN¥112.0mCN¥104.9mCN¥141.2mCN¥160.4mCN¥157.9m
Operating incomeCN¥33.9mCN¥27.9mCN¥185.2mCN¥38.1mCN¥51.9mCN¥69.8mCN¥127.6mCN¥100.1m
Net incomeCN¥44.6mCN¥19.8mCN¥77.8mCN¥20.5mCN¥54.3mCN¥50.2mCN¥91.0mCN¥89.7m
Diluted earnings per share0.090.040.160.040.110.110.120.12
Cash from operations———CN¥201.0mCN¥53.0m−CN¥59.0m—CN¥178.0m
Capital spending−CN¥28.0m−CN¥20.0m−CN¥3.0m−CN¥10.0m−CN¥3.0m−CN¥19.0m−CN¥26.0m−CN¥28.0m
Free cash flow———CN¥191.0mCN¥50.0m−CN¥78.0m—CN¥150.0m
Total assetsCN¥3.88bnCN¥3.99bnCN¥3.89bnCN¥3.66bnCN¥3.58bnCN¥3.91bnCN¥3.64bnCN¥1.98bn
Cash and short-term investments———CN¥751.6mCN¥591.0mCN¥845.3mCN¥668.2mCN¥418.2m
DebtCN¥734.9mCN¥830.6mCN¥783.3mCN¥411.6mCN¥863.8mCN¥969.2mCN¥509.9mCN¥155.0m
Shareholders' equityCN¥1.40bnCN¥1.41bnCN¥1.39bnCN¥1.51bnCN¥1.58bnCN¥1.84bnCN¥1.79bnCN¥1.69bn

Financial ratios

Data as of 27 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin36.2%43.8%51.1%51.0%44.7%53.4%
Operating margin21.4%31.6%36.2%36.7%30.1%34.8%
Net margin12.2%26.3%30.8%32.0%24.9%29.6%
Return on equity15.1%19.3%20.1%27.5%23.9%22.4%
Return on assets5.4%9.5%16.9%22.9%15.0%15.5%
Free cash flow yield9.8%2.5%5.2%7.1%4.3%3.6%
Revenue growth31.4%23.1%-15.2%24.9%34.3%-14.0%
Earnings growth-39.2%5.1%-18.4%60.7%13.0%-27.7%
Current ratio2.87x2.26x4.70x4.36x1.36x1.54x
Debt to equity0.56x0.29x0.09x0.09x0.32x0.30x
Equity ratio35.6%49.1%84.3%83.3%62.8%69.1%
Interest coverage12.20x54.75x72.59x101.62x23.92x32.99x
R&D as a share of sales4.9%3.8%3.7%3.8%4.0%3.8%
Buybacks as a share of market value36.6%-6.9%-1.8%-11.8%11.8%5.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.1%18.1%18.1%
Operating income-7.2%7.2%19.6%
Net income-19.5%-1.1%13.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin39.5%44.5%45.5%46.8%
Operating margin25.8%30.4%30.9%31.5%
Net margin18.3%24.0%24.7%25.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings73.034.511.511.011.717.515.611.112.5
Price to sales8.99.13.53.52.95.25.53.13.0

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 29 May 2025.

FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017
Paid in the year0.4290.3060.4080.2190.1560.1020.0470.186
  • 7-for-5 split · 29 May 2025
  • 7-for-5 split · 31 May 2024
  • 7-for-5 split · 12 Jun 2023
  • 7-for-5 split · 28 Apr 2020
  • 7-for-5 split · 12 Jul 2018

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.